Cited by 75Bacterial Infections and VaccinesMicrobial infections and disease researchHIV/AIDS Research and Interventions

Increased risk for meningococcal disease among men who have sex with men in the United States, 2012–2015

Open access
Folaranmi, Temitope A, Kretz, Cecilia B, Kamiya, Hajime, MacNeil, Jessica R, Whaley, Melissa J, Blain, Amy, Antwi, Mike, Dorsinville, Marie +12 more·2017·Clinical Infectious Diseases

Abstract

BACKGROUND: Several clusters of serogroup C meningococcal disease among men who have sex with men (MSM) have been reported in the United States in recent years. The epidemiology and risk of meningococcal disease among MSM is not well described. METHODS: All meningococcal disease cases among men aged 18-64 years reported to the National Notifiable Disease Surveillance System between January 2012 and June 2015 were reviewed. Characteristics of meningococcal disease cases among MSM and men not known to be MSM (non-MSM) were described. Annualized incidence rates among MSM and non-MSM were compared through calculation of the relative risk and 95% confidence intervals. Isolates from meningococcal disease cases among MSM were characterized using standard microbiological methods and whole-genome sequencing. RESULTS: Seventy-four cases of meningococcal disease were reported among MSM and 453 among non-MSM. Annualized incidence of meningococcal disease among MSM was 0.56 cases per 100000 population, compared to 0.14 among non-MSM, for a relative risk of 4.0 (95% confidence interval [CI], 3.1-5.1). Among the 64 MSM with known status, 38 (59%) were infected with human immunodeficiency virus (HIV). HIV-infected MSM had 10.1 times (95% CI, 6.1-16.6) the risk of HIV-uninfected MSM. All isolates from cluster-associated cases were serogroup C sequence type 11. CONCLUSIONS: MSM are at increased risk for meningococcal disease, although the incidence of disease remains low. HIV infection may be an important factor for this increased risk. Routine vaccination of HIV-infected persons with a quadrivalent meningococcal conjugate vaccine in accordance with Advisory Committee on Immunization Practices recommendations should be encouraged.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/cid/cix438

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Folaranmi, T. A., Kretz, C. B., Kamiya, H., MacNeil, J. R., Whaley, M. J., Blain, A., Antwi, M., Dorsinville, M., Pacilli, M., Smith, S., Civen, R., Ngo, V., Winter, K., Harriman, K., Wang, X., Bowen, V. B., Patel, M., Martin, S., Misegades, L., & Meyer, S. A.
Affiliations
  • Centers for Disease Control and Prevention (US)
  • National Center for Immunization and Respiratory Diseases (US)
  • New York City Department of Health and Mental Hygiene (US)
  • Chicago Department of Public Health (US)
  • Los Angeles County Department of Public Health (US)
  • California Department of Public Health (US)
Corresponding author
Meyer, Sarah A
Venue
Clinical Infectious Diseases
Published
2017-05-13
Volume
65
Issue
5
Pages
756-763
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2612185004
Cited by
75
References
27
Citations by year
2026: 4 · 2025: 7 · 2024: 9 · 2023: 8 · 2022: 3 · 2021: 2 · 2020: 14 · 2019: 12 · 2018: 15 · 2017: 1
FWCI
9.30
Type
journal article
Language
en
Open access
Licence
public-domain
Locations
  • Clinical Infectious Diseases (publishedVersion, public-domain)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • New York City Department of Health and Mental Hygiene
  • California Department of Public Health
  • National Institutes of Health (CC999999)
  • Centers for Disease Control and Prevention
Topics
  • Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
  • Life Sciences › Immunology and Microbiology › Microbiology › Microbial infections and disease research
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
Keywords
meningococcal disease, men who have sex with men, serogroup C meningococcal disease, HIV infection, incidence, whole genome sequencing, ST11, quadrivalent meningococcal conjugate vaccine, vaccination, notifiable disease surveillance, disease clusters
MeSH terms
Adolescent, Adult, Humans, Male, Meningococcal Infections, Middle Aged, Retrospective Studies, Risk Factors, United States, HIV Infections, Incidence, Homosexuality, Male, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review